Labcorp Q1 revenue $3.54B (+5.8%), adjusted EPS $4.25 (+10.6%); raises FY guidance

LABCORP HOLDINGS INC.

2026-Q1 EPS reported $3.35 revenue$3,537,600,000

Q1 diluted EPS $3.35 (+32.8% YoY); adjusted EPS $4.25 vs $3.84 consensus.
FY2026 guidance raised: revenue growth 5.0%–6.1%, Adj. EPS $17.70–$18.35 (midpoint $18.03, +$0.13).
Diagnostics revenue $2.76B (+5.0%); adjusted margin 16.6% (+30bps). Biopharma Labs revenue $780.6M (+8.2%).
Operating cash flow $191.5M (vs $18.5M); free cash flow $70.5M (vs -$107.5M).
Completed acquisition of Crouse Health lab assets; partnerships with CHOP, Illumina, Optum.ai, PathAI.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

LABCORP HOLDINGS INC. reported first quarter ended March 31, 2026 results: revenue $3.54 billion, net income Net Earnings Attributable to Labcorp Holdings Inc. $ 277.8 $ 212.8, EPS $3.35. Guidance raised.

Period: first quarter ended March 31, 2026
Revenue: $3.54 billion
Net income: Net Earnings Attributable to Labcorp Holdings Inc. $ 277.8 $ 212.8
EPS: $3.35
Guidance: raised
Result: reported results

Exact text from the filing

Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance • Results from Operations for first quarter 2026 versus first quarter 2025: ◦ Revenue: $3.54 billion vs. $3.35 billion, up 5.8% ◦ Diluted EPS: $3.35 vs. $2.52, up 32.8% ◦ Adjusted EPS: $4.25 vs. $3.84, up 10.6% • Raised Full-Year Enterprise Revenue and Adjusted EPS guidance: ◦ Revenue guidance of 5.0% to 6.1%; up 20 basis points at the midpoint ◦ Adjusted EPS range of $17.70 to $18.35; up 13 cents at the midpoint

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

LABCORP HOLDINGS INC. filing history →

Source: SEC EDGAR

accession 0000920148-26-000135

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.